EFSA published on 31.03.2020 a reasoned opinion on the evaluation of confirmatory data for nitrophenolates.
1st April 2020
EFSA opinion MRL confirmatory data nitrophenolates
01April
3rd February 2020
EFSA Art.12 MRL review fenazaquin
03February
On 30.01.2020 EFSA published a reasoned opinion on the Art. 12 review of existing MRLs for fenazaquin.
31st January 2020
EFSA Art.12 review MRLs spinetoram
31January
On 30.01.2020 EFSA published its reasoned opinion on the Art. 12 review of the MRLs of spinetoram.
31st January 2020
EFSA Art.12 MRL review terbuthylazine
On 30.01.2020 EFSA published a reasoned opinion on the Art.12 MRL review of terbuthylazine.
29th January 2020
EFSA Art. 12 review MRLs proquinazid
29January
EFSA published a reasoned opinion on the Art.12 review of existing MRLs for proquinazid.
29th January 2020
EFSA Art.12 review cycloxydim
EFSA published on 28.01.2020 a reasoned opinion on the Art.12 review of the MRLs of cycloxydim.
28th January 2020
EFSA Art.12 MRL review ametoctradin
28January
EFSA published on 29.01.2020 a reasoned opinion on the Art. 12 MRL review of ametoctradin.
28th January 2020
EFSA Art.12 review metamitron
EFSA published a reasoned opinion on the Art. 12 MRL review of metamitron.
23rd January 2020
EFSA abamectin review Art. 12 confirmatory data
23January
EFSA published on 23.01.2020 a reasoned opinion on the review of confirmatory data submitted following the Art. 12 review of abamectin. The report also covers the modification of MRLs in various...
23rd January 2020
EFSA Art. 12 MRL review spirotetramat
On 23.01.2020 EFSA published a reasoned opinion on the Art. 12 MRL review for spirotetramat.
23rd January 2020
EFSA Art.12 MRL review tefluthrin
EFSA published on 22.01.2020 a reasoned opinion on the Art. 12 MRL review of tefluthrin.
23rd January 2020
EFSA Art. 12 MRL review of bixafen MRLs
EFSA published on 22.01.2020 a reasoned opinion on the review of MRLs of bixafen.
23rd January 2020
EFSA Art. 12 MRL review 1-methylcyclopropene
EFSA published on 22.01.2020 a reasoned opinion on the Art.12 review of the MRLs of 1-methylcyclopropene.
23rd January 2020
EFSA Art.12 MRL review diclofop
EFSA published on 22.01.2020 a reasoned opinion on the review of the MRLs of diclofop(-methyl).
23rd January 2020
EFSA Art. 12 MRL review ipconazole
EFSA published on 22.01.2020 a reasoned opinion on the review of MRLs for ipconazole under Art. 12 of the MRL Regulation.
16th January 2020
Thiencarbazone Art. 12 review published
16January
EFSA published an Article 12 reasoned opinion on thiencarbazone.
16th January 2020
Fluxapyroxad Art. 12 MRL Review
EFSA published on 16.01.2020 a reasoned opinion on the Art. 12 MRL review of fluxapyroxad.
22nd December 2019
EFSA reports on substances the need no Art. 12 review
22December
EFSA published on 19.12.2019 another statement on substances for which an Art. 12 review is no longer considered necessary.
15th October 2019
Cymoxanil, Article 12 confirmatory data review
15October
On 15.10.2019 EFSA published a reasoned opinion (report 5823) on the evaluation of confirmatory data following the Article 12 review for cymoxanil.
25th September 2019
MRL Regulation imazalil
25September
On 25.09.2019 Regulation 2019/1582 of 25.09.2019 was published in the Official Journal, amending the MRLs for imazalil.